Concepedia

Toshiki Hatanaka

TH

9

Publications

364

Citations

9

H-Index

2004

Active since

Affiliations

Astellas Pharma (Japan)(Current)

GlaxoSmithKline (Japan)

Toshiki Hatanaka is an author at Astellas Pharma (Japan) specializing in physiology, medicine, and pharmacology.

Top concepts

Publications per year

2004–2018

9

Publications

9

In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats

Akiyoshi Ohtake, Masashi Ukai, Toshiki Hatanaka et al. · European Journal of Pharmacology · 2004 · 117 citations

, , +4

Pharmacological Characterization of a New Antimuscarinic Agent, Solifenacin Succinate, in Comparison with Other Antimuscarinic Agents

Akiyoshi Ohtake, Chikashi Saitoh, Hironori Yuyama et al. · Biological and Pharmaceutical Bulletin · 2007 · 72 citations · Full text

In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats

Toshiki Hatanaka, Masashi Ukai, Mai Watanabe et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2012 · 46 citations

, , +7

Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats

Toshiki Hatanaka, Masashi Ukai, Mai Watanabe et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2012 · 34 citations

, , +8

The new radioligand [3H]-L 748,337 differentially labels human and rat β3-adrenoceptors

Jan–Peter van Wieringen, Martina B. Michel-Reher, Toshiki Hatanaka et al. · European Journal of Pharmacology · 2013 · 24 citations · Full text

, , +6

Rows per page

1–5 of 9